Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Enterprise Value: 2016-2025

Historic Enterprise Value for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $467.2 million.

  • Organogenesis Holdings' Enterprise Value rose 28.90% to $467.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $135.7 million, marking a year-over-year increase of 73.33%. This contributed to the annual value of $288.1 million for FY2024, which is 33.88% down from last year.
  • Per Organogenesis Holdings' latest filing, its Enterprise Value stood at $467.2 million for Q3 2025, which was up 21.07% from $385.9 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Enterprise Value registered a high of $2.3 billion during Q1 2021, and its lowest value of $190.0 million during Q1 2023.
  • In the last 3 years, Organogenesis Holdings' Enterprise Value had a median value of $346.3 million in 2023 and averaged $344.7 million.
  • Its Enterprise Value has fluctuated over the past 5 years, first surged by 575.39% in 2021, then tumbled by 82.73% in 2022.
  • Quarterly analysis of 5 years shows Organogenesis Holdings' Enterprise Value stood at $1.1 billion in 2021, then crashed by 81.77% to $195.8 million in 2022, then skyrocketed by 122.54% to $435.7 million in 2023, then crashed by 33.88% to $288.1 million in 2024, then rose by 28.90% to $467.2 million in 2025.
  • Its last three reported values are $467.2 million in Q3 2025, $385.9 million for Q2 2025, and $430.9 million during Q1 2025.